Jove
Visualize
Contáctanos
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Videos de Conceptos Relacionados

Aggression01:47

Aggression

30.4K
Humans engage in aggression when they seek to cause harm or pain to another person. Aggression takes two forms depending on one’s motives: hostile or instrumental. Hostile aggression is motivated by feelings of anger with intent to cause pain; a fight in a bar with a stranger is an example of hostile aggression. In contrast, instrumental aggression is motivated by achieving a goal and does not necessarily involve intent to cause pain (Berkowitz, 1993); a contract killer who murders for...
30.4K
Renal Drug Excretion: Tubular Reabsorption01:25

Renal Drug Excretion: Tubular Reabsorption

921
Tubular reabsorption, a process occurring post-glomerular filtration of drugs in the renal tubule, is a critical determinant of drug half-life. During the process of renal excretion, as the glomerular filtrate progresses to the distal convoluted tubule (DCT), drugs that are highly permeable, lipophilic, and nonionized undergo passive reabsorption from the tubular fluid into the surrounding peritubular capillaries. This reabsorption process restricts their elimination through the kidneys. This...
921
Renal Drug Excretion: Tubular Secretion01:28

Renal Drug Excretion: Tubular Secretion

949
Active tubular secretion is a robust, energy-demanding process that utilizes carrier systems to transport drugs into renal tubules. The active renal secretion systems include the organic anion transporter (OAT) for weak acids and the organic cation transporter (OCT) for weak bases. Structurally similar drugs can compete for the same transporter, potentially leading to drug accumulation and toxicity. However, this principle can be exploited therapeutically. One example is probenecid (Probalan),...
949
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

1.1K
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
1.1K
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

1.2K
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.2K
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

521
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
521

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

A Hospital Level Analysis of 30-Day Readmission Performance for Heart Failure Patients and Long-Term Survival: Findings from Get With The Guidelines-Heart Failure.

American heart journal·2018
Same author

Early impact of guideline publication on angiotensin-receptor neprilysin inhibitor use among patients hospitalized for heart failure.

American heart journal·2018
Same author

Characteristics and Treatments of Patients Enrolled in the CHAMP-HF Registry Compared With Patients Enrolled in the PARADIGM-HF Trial.

Journal of the American Heart Association·2018
Same author

Home-Time After Discharge Among Patients Hospitalized With Heart Failure.

Journal of the American College of Cardiology·2018
Same author

Maximizing benefits and mitigating risks with mineralocorticoid receptor antagonist therapy.

European journal of heart failure·2018
Same author

Health Status Disparities by Sex, Race/Ethnicity, and Socioeconomic Status in Outpatients With Heart Failure.

JACC. Heart failure·2018

Video Experimental Relacionado

Updated: Feb 15, 2026

Renal Ischaemia Reperfusion Injury: A Mouse Model of Injury and Regeneration
12:27

Renal Ischaemia Reperfusion Injury: A Mouse Model of Injury and Regeneration

Published on: June 7, 2014

51.4K

El empeoramiento de la función renal en pacientes con insuficiencia cardíaca aguda sometidos a diuresis agresiva no

Tariq Ahmad1, Keyanna Jackson1, Veena S Rao1

  • 1Sections of Cardiovascular Medicine (T.A., K.J., V.S.R., J.M.T.).

Circulation
|January 21, 2018
PubMed
Resumen
Este resumen es generado por máquina.

El empeoramiento de la función renal durante el tratamiento de la insuficiencia cardíaca aguda con diuresis agresiva no está relacionado con la lesión tubular renal. Los biomarcadores para la lesión tubular no aumentaron, lo que sugiere cambios funcionales en lugar de daño.

Palabras clave:
lesión renal agudaLos biomarcadoresinsuficiencia cardíacaInsuficiencia renal

Más Videos Relacionados

Author Spotlight: Unveiling Prognostic Indicators in Heart Failure - The Role of Phase Angle and Bioelectrical Impedance Analysis
04:05

Author Spotlight: Unveiling Prognostic Indicators in Heart Failure - The Role of Phase Angle and Bioelectrical Impedance Analysis

Published on: June 30, 2023

2.9K
Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
05:16

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure

Published on: June 10, 2025

666

Videos de Experimentos Relacionados

Last Updated: Feb 15, 2026

Renal Ischaemia Reperfusion Injury: A Mouse Model of Injury and Regeneration
12:27

Renal Ischaemia Reperfusion Injury: A Mouse Model of Injury and Regeneration

Published on: June 7, 2014

51.4K
Author Spotlight: Unveiling Prognostic Indicators in Heart Failure - The Role of Phase Angle and Bioelectrical Impedance Analysis
04:05

Author Spotlight: Unveiling Prognostic Indicators in Heart Failure - The Role of Phase Angle and Bioelectrical Impedance Analysis

Published on: June 30, 2023

2.9K
Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
05:16

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure

Published on: June 10, 2025

666

Área de la Ciencia:

  • Nefrología
  • Cardiología
  • Investigación de biomarcadores

Sus antecedentes:

  • El empeoramiento de la función renal (WRF) durante el tratamiento de la insuficiencia cardíaca aguda (AHF) con diuresis agresiva puede deberse a una lesión tubular renal o a cambios hemodinámicos.
  • Los nuevos biomarcadores como NGAL, NAG y KIM-1 pueden cuantificar la lesión tubular.

Objetivo del estudio:

  • Investigar la asociación entre los biomarcadores de la lesión tubular y el WRF en pacientes con FHA sometidos a diuresis agresiva.
  • Para explorar las implicaciones del pronóstico de WRF y la lesión tubular en esta población de pacientes.

Principales métodos:

  • Análisis de 283 pacientes del ensayo multicéntrico ROSE-AHF con biomarcadores de referencia y de 72 horas en orina.
  • WRF se define como una disminución de ≥20% en la tasa de filtración glomerular estimada de la cistatina C.
  • Evaluación de los niveles de NGAL, NAG y KIM-1 en relación con el WRF y la supervivencia.

Principales resultados:

  • La diuresis agresiva (mediana de 560 mg equivalentes de furosemida) indujo una producción urinaria significativa pero no aumentó los niveles de NAG o KIM-1.
  • Los niveles de NGAL disminuyeron ligeramente (P< 0,001).
  • WRF se produjo en el 21,2% de los pacientes y no se asoció con elevados biomarcadores de lesión tubular (P>0,21 para todos). Paradójicamente, el aumento de los niveles de biomarcadores se correlacionó con una mejor supervivencia.

Conclusiones:

  • La lesión tubular renal no está asociada con WRF en pacientes con FHA tratados con diuresis agresiva.
  • Los cambios observados en la función renal son probablemente funcionales o hemodinámicos, distintos de las lesiones renales agudas tradicionales.
  • Los hallazgos sugieren que WRF en este contexto puede no indicar daño renal parenquimal significativo.